The $20 bln Danish wind group’s shares sank amid a $9 bln rights issue linked to an ailing US project. Political turmoil is ...

Second-quarter profit for the S&P 500 is up 10%, beating Wall Street forecasts. But without Big Tech, the uptick falls to 6%, while sales grew just 2.4%. The remainder is explained by currency moves, ...

Novo Nordisk, GSK and others need to replenish their pipelines to replace drugs coming off patent. In the past, buying a promising biotech required paying a 100% premium. But high interest rates and ...

The South Asian nation is open to cutting Russian oil purchases to reduce a 50% US import tariff but Donald Trump’s attacks will, in the long run, only make it double down on its multipolar foreign ...

To stop perceived bias from BofA and its peers against his supporters, President Trump wants ‘reputation’ axed from customer ...

Shares of Match Group, owner of hook-up app Tinder, have collapsed by 80% since their peak in 2021. Fatigued younger users ...

The $210 bln Ozempic maker spends less than rivals on developing new drugs. That’s a problem as upstarts challenge its ...

Since unveiling a $9 bln stock swap to buy computing power supplier Core Scientific, the buyer’s shares have tumbled 30%.

David Zaslav will run the HBO half of the $30 bln media empire after it splits from slumping TV networks. He was paid an ...

Donald Trump doubled US levies on Indian imports to 50%. Even if New Delhi can halve that by stopping its purchases of ...

Sweden's EQT will pay $2.7 bln for the elevator maker. It's a good outcome for pushy shareholders following a five-year grind ...

As post-inflationary havoc ebbs and a slew of new funds flows, quarterly management fees surged at Blackstone, KKR, Apollo ...